Tokyo, Japan

Tatsurou Ichige

This inventor holds 1 USPTO granted patent. Top assignee: Institute of Medicinal Molecular Design, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tatsurou Ichige. Retrieved from https://idiyas.com/inventor/tatsurou-ichige

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Tatsurou Ichige

Introduction

Tatsurou Ichige is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patent work. His research focuses on developing compounds that can serve as active ingredients in medications.

Latest Patents

Ichige holds a patent for N-(3,4-disubstituted phenyl) salicylamide derivatives. This compound is represented by a specific formula and is designed to be useful in the prophylactic and therapeutic treatment of diseases caused by the activation of STAT6 and/or NF-κB. The patent highlights the versatility of the compound, which can include various substituents and functional groups.

Career Highlights

Ichige is affiliated with the Institute of Medicinal Molecular Design, Inc., where he continues to advance his research. His work has been instrumental in exploring new therapeutic avenues and enhancing the efficacy of medicinal compounds.

Collaborations

Ichige collaborates with esteemed colleagues such as Ryukou Tokuyama and Toshifumi Wakamatsu. Their combined expertise contributes to the innovative research environment at their institution.

Conclusion

Tatsurou Ichige's contributions to medicinal chemistry through his patent work exemplify the impact of innovation in healthcare. His ongoing research promises to lead to significant advancements in the treatment of various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…